Literature DB >> 16155000

Glucocorticoid-induced tumor necrosis factor receptor is a p21Cip1/WAF1 transcriptional target conferring resistance of keratinocytes to UV light-induced apoptosis.

Jian Wang1, Vikram Devgan, Marcella Corrado, Nita S Prabhu, Wafik S El-Deiry, Carlo Riccardi, Pier Paolo Pandolfi, Caterina Missero, G Paolo Dotto.   

Abstract

Glucocorticoid-induced tumor necrosis factor receptor (GITR) is a member of the tumor necrosis factor receptor superfamily, is expressed in T lymphocytes, and exerts an anti-apoptotic function in these cells. We reported that GITR is also highly expressed in the skin, specifically in keratinocytes, and that it is under negative transcriptional control of p21(Cip1/WAF1), independently from the cell cycle. Although GITR expression is higher in p21-deficient keratinocytes and skin, it is down-modulated with differentiation and in response to UVB. The combined analysis of keratinocytes with increased GITR expression versus normal keratinocytes and skin of mice with a disruption of the GITR gene indicates that this protein protects keratinocytes from UVB-induced apoptosis both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16155000     DOI: 10.1074/jbc.M507976200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors.

Authors:  Elisabeth Simboeck; Anna Sawicka; Gordin Zupkovitz; Silvia Senese; Stefan Winter; Franck Dequiedt; Egon Ogris; Luciano Di Croce; Susanna Chiocca; Christian Seiser
Journal:  J Biol Chem       Date:  2010-10-14       Impact factor: 5.157

2.  A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents.

Authors:  C Ritchlin; F Tausk
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

3.  The FoxO3a gene is a key negative target of canonical Notch signalling in the keratinocyte UVB response.

Authors:  Anna Mandinova; Karine Lefort; Alice Tommasi di Vignano; Wesley Stonely; Paola Ostano; Giovanna Chiorino; Haruhi Iwaki; Jotaro Nakanishi; G Paolo Dotto
Journal:  EMBO J       Date:  2008-04-03       Impact factor: 11.598

Review 4.  Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.

Authors:  Giuseppe Nocentini; Simona Ronchetti; Maria Grazia Petrillo; Carlo Riccardi
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

5.  Induction of GITRL expression in human keratinocytes by Th2 cytokines and TNF-α: implications for atopic dermatitis.

Authors:  A M Byrne; E Goleva; F Chouiali; M H Kaplan; Q A Hamid; D Y M Leung
Journal:  Clin Exp Allergy       Date:  2012-04       Impact factor: 5.018

Review 6.  Glucocorticoid-induced TNFR-related (GITR) protein and its ligand in antitumor immunity: functional role and therapeutic modulation.

Authors:  Theresa Placke; Hans-Georg Kopp; Helmut Rainer Salih
Journal:  Clin Dev Immunol       Date:  2010-09-26

7.  Optimal elevation of β-cell 11β-hydroxysteroid dehydrogenase type 1 is a compensatory mechanism that prevents high-fat diet-induced β-cell failure.

Authors:  Sophie Turban; Xiaoxia Liu; Lynne Ramage; Scott P Webster; Brian R Walker; Donald R Dunbar; John J Mullins; Jonathan R Seckl; Nicholas M Morton
Journal:  Diabetes       Date:  2012-02-07       Impact factor: 9.461

Review 8.  CD8+ T cells: GITR matters.

Authors:  Simona Ronchetti; Giuseppe Nocentini; Maria Grazia Petrillo; Carlo Riccardi
Journal:  ScientificWorldJournal       Date:  2012-04-30

Review 9.  The Role of the Cyclin Dependent Kinase Inhibitor p21cip1/waf1 in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics.

Authors:  Samar Al Bitar; Hala Gali-Muhtasib
Journal:  Cancers (Basel)       Date:  2019-09-30       Impact factor: 6.639

Review 10.  The Roles of Immunoregulatory Networks in Severe Drug Hypersensitivity.

Authors:  Yun-Shiuan Olivia Hsu; Kun-Lin Lu; Yun Fu; Chuang-Wei Wang; Chun-Wei Lu; Yu-Fen Lin; Wen-Cheng Chang; Kun-Yun Yeh; Shuen-Iu Hung; Wen-Hung Chung; Chun-Bing Chen
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.